Y
Yoriko Takahashi
Publications - 18
Citations - 666
Yoriko Takahashi is an academic researcher. The author has contributed to research in topics: DNA methylation & Gene. The author has an hindex of 8, co-authored 16 publications receiving 545 citations.
Papers
More filters
Journal ArticleDOI
Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer.
Hiromi Sakamoto,Kimio Yoshimura,Norihisa Saeki,Hitoshi Katai,Tadakazu Shimoda,Yoshihiro Matsuno,Daizo Saito,Haruhiko Sugimura,Fumihiko Tanioka,Shunji Kato,Norio Matsukura,Noriko Matsuda,Tsuneya Nakamura,Ichinosuke Hyodo,Tomohiro Nishina,Wataru Yasui,Hiroshi Hirose,Matsuhiko Hayashi,Emi Toshiro,Sumiko Ohnami,Akihiro Sekine,Yasunori Sato,Hirohiko Totsuka,Masataka Ando,Ryo Takemura,Yoriko Takahashi,Minoru Ohdaira,Kenichi Aoki,Izumi Honmyo,Suenori Chiku,Kazuhiko Aoyagi,Hiroki Sasaki,Shumpei Ohnami,Kazuyoshi Yanagihara,Kyong-Ah Yoon,Myeong-Cherl Kook,Yeon-Su Lee,Sook Ryun Park,Chan Gyoo Kim,Il Ju Choi,Teruhiko Yoshida,Yusuke Nakamura,Setsuo Hirohashi +42 more
TL;DR: It is found that PSCA is expressed in differentiating gastric epithelial cells, has a cell-proliferation inhibition activity in vitro and is frequently silenced in gastric cancer.
Journal ArticleDOI
Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease
Takashi Sato,Eri Arai,Takashi Kohno,Yoriko Takahashi,Sayaka Miyata,Koji Tsuta,Shun Ichi Watanabe,Kenzo Soejima,Tomoko Betsuyaku,Yae Kanai +9 more
TL;DR: DNA methylation profiles reflecting carcinogenetic factors such as smoking and COPD appear to be established in non‐cancerous lung tissue from patients with LADCs and may determine the aggressiveness of tumors developing in individual patients, and thus patient outcome.
Journal ArticleDOI
Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis.
Junko Kuramoto,Eri Arai,Ying Tian,Nobuaki Funahashi,Masaki Hiramoto,Takao Nammo,Yuichi Nozaki,Yoriko Takahashi,Nanako Ito,Ayako Shibuya,Hidenori Ojima,Aoi Sukeda,Yosuke Seki,Kazunori Kasama,Kazuki Yasuda,Yae Kanai +15 more
TL;DR: Genome-wide DNA methylation analysis indicated thatDNA methylation alterations are already present even at the precancerous NASH stage, clearly differing from such alterations in viral hepatitis or cirrhosis, and possibly continuing to participate in NASH-related multistage hepatocarcinogenesis.
Journal ArticleDOI
Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer.
Takeshi Makabe,Eri Arai,Takuro Hirano,Nanako Ito,Yukihiro Fukamachi,Yoriko Takahashi,Akira Hirasawa,Wataru Yamagami,Nobuyuki Susumu,Nobuyuki Susumu,Daisuke Aoki,Yae Kanai +11 more
TL;DR: Data indicate that genetically and epigenetically different pathways may participate in the development of EEs and LEs, and that DNA methylation profiling may help predict tumors that are less aggressive and amenable to fertility preservation treatment.
Journal ArticleDOI
Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas
Eri Arai,Masahiro Gotoh,Ying Tian,Hiromi Sakamoto,Masaya Ono,Akio Matsuda,Yoriko Takahashi,Sayaka Miyata,Hirohiko Totsuka,Suenori Chiku,Motokiyo Komiyama,Hiroyuki Fujimoto,Kenji Matsumoto,Tesshi Yamada,Teruhiko Yoshida,Yae Kanai +15 more
TL;DR: The data suggest that abnormalities of the spindle checkpoint pathway participate in CIMP‐positive renal carcinogenesis, and that AURKA and AURKB may be potential therapeutic targets in more aggressive CIMp‐positive RCCs.